肝胆胰外科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 肝胆胰外科威廉亚洲博彩公司

2018 日本威廉亚洲博彩公司 ：急性胆管炎和胆囊炎的抗生素治疗

2018-01-09 日本肝胆胰腺外科学会 J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16.

急性胆管炎胆囊炎抗生素治疗

2018年1月，日本肝胆胰腺外科学会(JSHBPS)更新发布了急性胆管炎和胆囊炎的抗生素治疗威廉亚洲博彩公司 ，抗生素治疗是急性胆管炎和急性胆囊炎患者的主要治疗措施，本文主要针对社区获得性和医院获得性感染合理应用抗生素治疗提供指导建议。

中文标题：

2018 日本威廉亚洲博彩公司 ：急性胆管炎和胆囊炎的抗生素治疗

英文标题：

Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.

发布机构：

日本肝胆胰腺外科学会

发布日期：

2018-01-09

简要介绍：

2018年1月，日本肝胆胰腺外科学会(JSHBPS)更新发布了急性胆管炎和胆囊炎的抗生素治疗威廉亚洲博彩公司 ，抗生素治疗是急性胆管炎和急性胆囊炎患者的主要治疗措施，本文主要针对社区获得性和医院获得性感染合理应用抗生素治疗提供指导建议。

 

拓展威廉亚洲博彩公司 ：与胆囊炎相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 日本威廉亚洲博彩公司 ：急性胆管炎和胆囊炎的抗生素治疗)] GetToolGuiderByIdResponse(projectId=1, id=2f0951c0015a5655, title=2018 日本威廉亚洲博彩公司 ：急性胆管炎和胆囊炎的抗生素治疗, enTitle=Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis., guiderFrom=J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16., authorId=null, author=, summary=2018年1月，日本肝胆胰腺外科学会(JSHBPS)更新发布了急性胆管炎和胆囊炎的抗生素治疗威廉亚洲博彩公司 ，抗生素治疗是急性胆管炎和急性胆囊炎患者的主要治疗措施，本文主要针对社区获得性和医院获得性感染合理应用抗生素治疗提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=552, associationName=日本肝胆胰腺外科学会, associationIntro=日语网站, copyright=0, guiderPublishedTime=Tue Jan 09 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年1月，日本肝胆胰腺外科学会(JSHBPS)更新发布了急性胆管炎和胆囊炎的抗生素治疗威廉亚洲博彩公司 ，抗生素治疗是急性胆管炎和急性胆囊炎患者的主要治疗措施，本文主要针对社区获得性和医院获得性感染合理应用抗生素治疗提供指导建议。 </P> <P> </P>拓展威廉亚洲博彩公司 ：<strong>与<font color=red>胆囊炎</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=4fae11c001a261a0" title="胆囊炎中医诊疗专家共识意见（2017）" target=_blank>胆囊炎中医诊疗专家共识意见（2017）</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=bb69f1c00120a843" title="慢性胆囊炎的维医诊疗标准" target=_blank>慢性胆囊炎的维医诊疗标准</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=f3d151c001135380" title="中国慢性胆囊炎、胆囊结石内科诊疗共识意见(2014年，上海)" target=_blank>中国慢性胆囊炎、胆囊结石内科诊疗共识意见(2014年，上海)</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=7c2251c00112e823" title="2014 WSES立场声明：急性胆囊炎" target=_blank>2014 WSES立场声明：急性胆囊炎</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=897101c000960079" title="2013 日本急性胆管炎、胆囊炎治疗东京威廉亚洲博彩公司 （更新版）" target=_blank>2013 日本急性胆管炎、胆囊炎治疗东京威廉亚洲博彩公司 （更新版）</a></li> 更多信息请点击：<a href="//www.nyrain.com/guideline/list.do?q=%E8%83%86%E5%9B%8A%E7%82%8E" target=_blank>有关胆囊炎更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=46309, tagName=急性胆管炎), TagDto(tagId=1039, tagName=胆囊炎), TagDto(tagId=4247, tagName=抗生素治疗)], categoryList=[CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10287, appHits=511, showAppHits=0, pcHits=6001, showPcHits=5175, likes=123, shares=20, comments=7, approvalStatus=1, publishedTime=Sun Jan 21 22:11:43 CST 2018, publishedTimeString=2018-01-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jan 21 22:11:43 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:33:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 日本威廉亚洲博彩公司 ：急性胆管炎和胆囊炎的抗生素治疗)])
2018 日本威廉亚洲博彩公司 ：急性胆管炎和胆囊炎的抗生素治疗
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191931, encodeId=d96711919317a, content=实用，有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:18:51 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914778, encodeId=db12914e7898, content=继续努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd525449029, createdName=TLzhuyanhui, createdTime=Sat Jan 09 01:14:32 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280938, encodeId=596828093857, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 22 10:53:15 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280903, encodeId=e64a28090375, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jan 22 09:05:22 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280876, encodeId=84cf2808e6dd, content=^_^^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Jan 22 07:04:53 CST 2018, time=2018-01-22, status=1, ipAttribution=)]
    2022-02-10 ms3000000637975859

    实用，有效

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191931, encodeId=d96711919317a, content=实用，有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:18:51 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914778, encodeId=db12914e7898, content=继续努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd525449029, createdName=TLzhuyanhui, createdTime=Sat Jan 09 01:14:32 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280938, encodeId=596828093857, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 22 10:53:15 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280903, encodeId=e64a28090375, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jan 22 09:05:22 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280876, encodeId=84cf2808e6dd, content=^_^^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Jan 22 07:04:53 CST 2018, time=2018-01-22, status=1, ipAttribution=)]
    2021-01-09 TLzhuyanhui

    继续努力学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191931, encodeId=d96711919317a, content=实用，有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:18:51 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914778, encodeId=db12914e7898, content=继续努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd525449029, createdName=TLzhuyanhui, createdTime=Sat Jan 09 01:14:32 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280938, encodeId=596828093857, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 22 10:53:15 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280903, encodeId=e64a28090375, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jan 22 09:05:22 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280876, encodeId=84cf2808e6dd, content=^_^^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Jan 22 07:04:53 CST 2018, time=2018-01-22, status=1, ipAttribution=)]
    2018-01-22 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191931, encodeId=d96711919317a, content=实用，有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:18:51 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914778, encodeId=db12914e7898, content=继续努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd525449029, createdName=TLzhuyanhui, createdTime=Sat Jan 09 01:14:32 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280938, encodeId=596828093857, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 22 10:53:15 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280903, encodeId=e64a28090375, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jan 22 09:05:22 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280876, encodeId=84cf2808e6dd, content=^_^^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Jan 22 07:04:53 CST 2018, time=2018-01-22, status=1, ipAttribution=)]
    2018-01-22 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191931, encodeId=d96711919317a, content=实用，有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:18:51 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914778, encodeId=db12914e7898, content=继续努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd525449029, createdName=TLzhuyanhui, createdTime=Sat Jan 09 01:14:32 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280938, encodeId=596828093857, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 22 10:53:15 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280903, encodeId=e64a28090375, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jan 22 09:05:22 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280876, encodeId=84cf2808e6dd, content=^_^^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Jan 22 07:04:53 CST 2018, time=2018-01-22, status=1, ipAttribution=)]
    2018-01-22 wqkm

    ^_^^_^^_^^_^

    0